Resources with keywords: vaccines
Patton ME, Moline HL, Whitaker M, et al.
Interim evaluation of respiratory syncytial virus hospitalization rates among infants and young children in the United States after introduction of respiratory syncytial virus prevention products (e.g., vaccines, long-acting monoclonal antibodies).
The FDA approved a new indication for ACAM2000, to include the prevention of mpox disease in individuals determined to be at high risk for mpox infection. ACAM2000 has been approved since 2007 for the prevention of smallpox disease in individuals determined to be at high risk for smallpox infection. ACAM2000 is a live replicating vaccinia virus vaccine.
Advisors to the WHO recently recommended a second malaria vaccine.
Moulia DL, Wallace M, Roper LE, et al.
Updated vaccine recommendations for children > 6 months and adults >65.
WHO Immunization, Vaccines, and Biologicals Department’s list of vaccine-preventable diseases
Hause AM, Marquez P, Zhang B, et al.
DeCuir J, Surie D, Zhu Y, et al.
